Celltrion Healthcare Ranks High in Search... Stock Price -0.26%
As of 1:32 PM on the 26th, Celltrion Healthcare is trading at 114,400 KRW, down 0.26% from the previous day. This marks a 25.99% increase compared to May 29. Celltrion Healthcare is known as the exclusive distributor of Celltrion's biosimilars.
Today, foreigners have net sold 117,528 shares of Celltrion Healthcare, and institutions have net sold 7,000 shares, according to provisional data. Over the past five days, individual investors have net sold 467,457 shares, while foreigners and institutions have net bought 200,726 shares and 225,036 shares, respectively.
[Table] Net Trading Volume of Foreigners and Institutions (Unit: shares)
※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
Hot Picks Today
!["Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①](https://cwcontent.asiae.co.kr/asiaresize/93/2026051414165763158_1778735817.jpg)
"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- "If That's the Case, Why Not Just Buy Stocks?" ETFs in Name Only, Now 'Semiconductor-Heavy' and a Playground for Short-Term Traders
- [Breaking] Two Days Before Strike... Central Labor Relations Commission Chair Park Soogeun Says "Differences Narrowing... Possibility of Agreement"
- Individual Investors Absorb Foreign Sell-Off... Concerns Over Becoming "Cannon Fodder" Emerge
- "No Cure Available, Spread Accelerates... Already 105 Dead, American Infected"
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
